FHLC vs HLTH: Grades, Fees and Holdings Compared

Fidelity MSCI Health Care Index ETF

FHLCANYSE Arca

Tema Healthcare AI ETF

HLTHDNasdaq

Overlap

11.1%by weight

Expense ratio

FHLC −0.67pt a year

FHLC0.08%HLTH0.75%

Avg volume · 30D

FHLC 24.1×the volume

FHLC246KHLTH10.2K

FHLC vs HLTH Performance

Jul 31, 2026 – Nov 2, 2026

+12.4%FHLC+7.4%HLTH

Expense ratio: FHLC 0.08%, better; HLTH 0.75%
Fund size: FHLC $3.54B; HLTH $12M
1Y total return: FHLC +28.5%; HLTH No data
Yield (12M): FHLC 1.15%; HLTH No data
Holdings: FHLC 344; HLTH 33
Avg volume (30D): FHLC 246K sh, better; HLTH 10.2K sh
NAV per share: FHLC $88.53; HLTH $28.63
52W range

ETF.net Grade

Pillar letters and Scores for FHLC, HLTH, with each pillar’s weight
Pillar	FHLC	HLTH
Cost30% weight	A98Higher	F8
Mission25% weight	A81	Not scored
Risk15% weight	A79Higher	C49
Tradability15% weight	A79Higher	D29
Holdings10% weight	C54	B62Higher
Durability5% weight	A77Higher	D27

Rank among Health Care (Broad) funds

How we build Categories ›

Same Category. FHLC and HLTH are both graded against the same 25 Health Care (Broad) funds, so their Grades compare head to head.

Health Care (Broad)⁠

Category · 25 funds

See all 25 ›

FHLC ranks 2nd and HLTH 21st of 25 funds in the Health Care (Broad) Category.

Rank 1AXLVState Street Health Care Select Sector SPDR ETFScore 85
Rank 2AFHLCFidelity MSCI Health Care Index ETFScore 83
Rank 3AVHTVanguard Health Care ETFScore 77
Rank 20DHRTSTema Heart & Health ETFScore 31
Rank 21DHLTHTema Healthcare AI ETFScore 28
Rank 22DMDEVFirst Trust Indxx Medical Devices ETFScore 27

Our read on each fund

ETF.net Research

FHLCAFidelity MSCI Health Care Index ETF

HLTHDTema Healthcare AI ETF

In short

FHLC Health care, whole market. FHLC tracks an MSCI index that runs from mega-cap pharma down to small-cap biotech and device makers, roughly 400 names, for 0.08% a year.

HLTH No data

Stated mandate

FHLC The fund seeks to track the performance of the MSCI USA IMI Health Care Index before fees and expenses.

HLTH No data

Why people hold it

FHLC Charges 0.08% a year against a 0.50% median for broad health care ETFs. Only XLV matches that sticker; VHT sits a hair above.
The IMI index it follows reaches for about 99% of US free-float market value, so smaller biotech and device names ride along with the pharma giants.msci.com
Mirrors its benchmark closely, one of the tighter tracking jobs among broad health care funds. Distributions come quarterly.
Fidelity has run it since 2013, and it has grown into a multi-billion-dollar fund with a plain vanilla index mandate.fidelity.com

HLTH No data

Worth knowing

FHLC One sector, one country. Drug-pricing politics, patent cliffs and FDA rulings move the whole portfolio at once.
Free-float cap weighting means a handful of mega-cap insurers and drugmakers carry most of the weight; that long tail of small names counts for less than it looks.msci.com
Moderately traded rather than the category's volume leader, so spreads matter more on large or hurried orders.

HLTH No data

Full FHLC profile⁠

Full HLTH profile⁠

FHLC vs HLTH Holdings

How FHLC and HLTH differ

Overlap by weight

11.1%

Shared holdings make up 87.2% of HLTH and 11.1% of FHLC.

Level by level

Holdings23 in both11.1%
Asset classEquity100%
Countryby domicile99.6%

Sector

No Sector split for HLTH.

Country, concentration and asset class

Country by domicile

Country weights in FHLC and HLTH, widest gap first
Country	More in FHLCMore in HLTH	FHLC	HLTH
United States	HLTH +0.4 points	99.6%	100.0%
United Kingdom	FHLC +0.3 points	0.3%	0.0%
Switzerland	FHLC +0.1 points	0.1%	0.0%
Canada	Same weight	0.0%	0.0%
Netherlands	Same weight	0.0%	0.0%

Concentration

Weight in the 10 largest Holdings

FHLC53.3%
HLTH50.9%

Securities held

FHLC343
HLTH32

Asset class

FHLC: Equity
HLTH: Equity

Holdings

Only in FHLC320
In both23
Only in HLTH9

Only in FHLC

320 securities, 90.3% of FHLC by weight

Eli Lilly & Co14.62%
Johnson & Johnson8.48%
AbbVie Inc6.71%
UnitedHealth Group Inc4.76%
Merck & Co Inc New4.76%
Amgen Inc3.24%
Gilead Sciences Inc2.73%
Abbott Laboratories2.38%
Pfizer Inc2.24%
Danaher Corp1.91%
Bristol-Myers Squibb Co1.64%
Medtronic PLC1.59%
Mckesson Corp1.50%
Cvs Health Corp1.48%
Stryker Corp1.30%
Securities Lending Cf1.28%
Regeneron Pharmaceuticals Inc1.23%
Elevance Health Inc1.17%
Cigna Group (The)1.02%
Moderna Inc0.96%
Hca Healthcare Inc0.95%
Boston Scientific Corp0.80%
Cencora Inc0.79%
Becton Dickinson & Co0.70%
Edwards Lifesciences Corp0.68%
Humana Inc0.64%
Agilent Technologies Inc0.64%
Veeva Sys Inc Class A0.59%
Waters Corp0.59%
Iqvia Holdings Inc0.58%
Idexx Labs Inc0.56%
Biogen Inc0.48%
Ge Healthcare Technologies Inc0.45%
Mettler-Toledo Intl Inc0.44%
Centene Corp0.44%
Zoetis Inc Class A0.43%
Resmed Inc0.43%
Labcorp Holdings Inc0.38%
West Pharmaceutical Svcs Inc0.38%
Quest Diagnostics Inc0.36%
Royalty Pharma PLC0.36%
Insmed Inc0.31%
Tenet Healthcare Corp0.30%
United Therapeutics Corp Del0.29%
Viatris Inc0.29%
Steris PLC0.28%
Alnylam Pharmaceuticals Inc0.28%
Incyte Corp0.26%
Roivant Sciences Ltd0.25%
Zimmer Biomet Hldgs Inc0.24%

Only in HLTH

9 securities, 12.5% of HLTH by weight

Generate Biomedicines Inc2.77%
Oscar Health Inc1.91%
Parabilis Medicines Inc1.87%
City Therapeutics Inc1.54%
Iambic Therapeutics Inc1.22%
Alamar Biosciences Inc1.05%
Insilico Medicine Cayman Topco0.82%
Century Therapeutics Inc0.82%
Scribe Therapeutics Inc0.44%

Weight gaps

All 23 Holdings in both funds, largest gap first.

Holding weights in FHLC and HLTH, widest gap first
Holding	More in FHLCMore in HLTH	FHLC	HLTH
10X Genomics IncTXG	HLTH +6.28 points	0.09%	6.37%
Twist Bioscience CorpTWST	HLTH +5.39 points	0.11%	5.50%
Natera IncNTRA	HLTH +4.84 points	0.73%	5.57%
Cytokinetics IncCYTK	HLTH +4.71 points	0.10%	4.81%
Cogent Biosciences IncCOGT	HLTH +4.51 points	0.05%	4.56%
Revolution Medicines IncRVMD	HLTH +4.44 points	0.42%	4.86%
Guardant Health IncGH	HLTH +4.33 points	0.28%	4.61%
Absci CorpABSI	HLTH +4.02 points	0.02%	4.04%
Illumina IncILMN	HLTH +3.88 points	0.45%	4.33%
Cardinal Health IncCAH	HLTH +3.41 points	0.76%	4.17%
Intuitive Surgical IncISRG	HLTH +3.26 points	1.97%	5.23%
Stoke Therapeutics IncSTOK	HLTH +3.21 points	0.01%	3.22%
Dexcom IncDXCM	HLTH +3.12 points	0.41%	3.52%
Vertex Pharmaceuticals IncVRTX	HLTH +2.97 points	1.83%	4.80%
Arrowhead Pharmaceuticals IncARWR	HLTH +2.82 points	0.09%	2.91%
Tempus Ai IncTEM	HLTH +2.69 points	0.10%	2.79%
Heartflow IncHTFL	HLTH +2.47 points	0.05%	2.52%
Beam Therapeutics IncBEAM	HLTH +2.37 points	0.03%	2.40%
Kymera Therapeutics IncKYMR	HLTH +2.36 points	0.08%	2.44%
Relay Therapeutics IncRLAY	HLTH +1.79 points	0.03%	1.82%
Thermo Fisher Scientific IncTMO	HLTH +1.24 points	3.34%	4.58%
Ionis Pharmaceuticals IncIONS	HLTH +1.02 points	0.09%	1.11%
Schrodinger IncSDGR	HLTH +1.02 points	0.02%	1.04%

All 365 FHLC holdings⁠All 33 HLTH holdings⁠

How we measure overlap

Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.

FHLC vs HLTH Cost

Overpaying HLTH vs FHLC

$12,709

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

FHLC 0.084%
$1,773
HLTH 0.75%
$14,482

Amount$10,000

Years30 years

Cost over time

FHLC 0.084%
HLTH 0.75%
Overpaying

Year by year

Year	FHLC	HLTH	Overpaying
10	$154	$1,336	$1,182
20	$603	$5,078	$4,475
30	$1,773	$14,482	$12,709

Expense ratio

0.08%FHLC, cheaper
0.75%HLTH

FHLC0.08%HLTH0.75%

0.08%0.85%

Middle half of Health Care (Broad) funds
Median 0.50%

FHLC 2nd cheapest of 25 funds

HLTH 22nd cheapest of 25 funds

FHLC vs HLTH Dividends

Last 12 months to Nov 2, 2026

Yield (12M): FHLC 1.15%; HLTH No data
Payout (12M): FHLC $1.02; HLTH None
Last payment: FHLC $0.25; HLTH No data
Ex-dividend: FHLC Sep 18, 2026; HLTH No data
Paid on: FHLC Sep 22, 2026; HLTH No data
Frequency: FHLC Quarterly; HLTH No data

Distribution history

Per share, 2017 to 2026, same scale for both

FHLCQuarterly · 40 paymentsAll FHLC payments⁠

HLTHAll HLTH payments⁠

No distribution history available.

FHLC vs HLTH Risk

Fall from peak · 5 years

This chart needs five years of history for both funds.

Risk facts

VolatilityStd dev, 3 years: FHLC 14.5%HLTH No data
Return per unit of riskSharpe ratio, 3 years: FHLC 0.83HLTH No data
Worst fallMax drawdown, 5 years: FHLC −17.7%HLTH No data
Market sensitivityBeta, 5 years: FHLC 0.59HLTH 3.41; Market = 1

FHLC and HLTH in the news

All news⁠

Category Review
Health care funds trail the S&P 500 this year
Updated Oct 7, 2026FHLC
Deep Dive
Health care's 1.8% week was four large caps, not a biotech rally
Sep 19, 2026FHLC

Popular comparisons

FHLCAvsXLVA
Fidelity MSCI Health Care Index ETF · State Street Health Care Select Sector SPDR ETF
Expense ratio
0.08% · 0.08%
Category
HLTHDvsXLVA
Tema Healthcare AI ETF · State Street Health Care Select Sector SPDR ETF
Expense ratio
0.75% · 0.08%
Category
FHLCAvsVHTA
Fidelity MSCI Health Care Index ETF · Vanguard Health Care ETF
Expense ratio
0.08% · 0.09%
Category
HLTHDvsVHTA
Tema Healthcare AI ETF · Vanguard Health Care ETF
Expense ratio
0.75% · 0.09%
Category
FHLCAvsXHSA
Fidelity MSCI Health Care Index ETF · State Street SPDR S&P Health Care Services ETF
Expense ratio
0.08% · 0.35%
Category
HLTHDvsXHSA
Tema Healthcare AI ETF · State Street SPDR S&P Health Care Services ETF
Expense ratio
0.75% · 0.35%
Category

FHLC vs HLTH

In short

Stated mandate

Why people hold it

Worth knowing

How FHLC and HLTH differ

Level by level

Sector

Country, concentration and asset class

Country by domicile

Concentration

Asset class

Holdings

Only in FHLC

Only in HLTH

Weight gaps

Cost over time

Year by year

Distribution history

Fall from peak · 5 years

Risk facts

Health care funds trail the S&P 500 this year

Health care's 1.8% week was four large caps, not a biotech rally

How FHLC and HLTH differ

Level by level

Sector

Country, concentration and asset class

Country by domicile

Concentration

Asset class

Holdings

Only in FHLC

Only in HLTH

Weight gaps